Brief: Oryzon Expands Patent Portfolio For Iadademstat And Vafidemstat

ORYZON Genomics SA

16/09/2025 06:59

Sept 16 (Reuters) - Oryzon Genomics SA ORY.MC:

EXPANDS PATENT PORTFOLIO FOR IADADEMSTAT AND VAFIDEMSTAT

AUSTRALIAN PATENT OFFICE ISSUED DECISION TO GRANT FOR ORYZON'S PATENT APPLICATION

AUSTRALIAN PATENT FOR IADADEMSTAT VALID UNTIL AT LEAST 2040

EUROPEAN PATENT OFFICE GRANTS PATENT FOR VAFIDEMSTAT FOR BEHAVIOR ALTERATIONS

EUROPEAN PATENT VALID UNTIL AT LEAST 2038

Source text

Further company coverage: ORY.MC

 (Gdansk Newsroom)

 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))